Abbott Laboratories buy Royal Bank of Canada
Start price
14.02.24
/
50%
€104.16
Target price
14.02.25
€119.35
Performance (%)
-1.00%
Price
04.10.24
€102.60
Summary
This prediction is currently active. With a performance of -1.00%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 14.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.887% | 1.887% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€94.80
04.06.24
04.06.24
€114.98
04.06.25
04.06.25
8.23%
04.10.24
04.10.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
3.98%
04.10.24
04.10.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
0.56%
04.10.24
04.10.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
0.62%
04.10.24
04.10.24